Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy
NCT ID: NCT01090531
Last Updated: 2020-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2009-08-31
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients
NCT05991531
Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory
NCT05376124
Real World Study of Chronic Viral Hepatitis
NCT04025944
"Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
NCT01732081
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
NCT03097952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* chronic hepatitis B
* HBV-DNA \< 100.000 IU/ml
* ALT ≤2 x ULN
* recent liver histology and/or FibroScan measurement
* willingness to sign informed consent
Exclusion Criteria
* chronic hepatitis B in immune tolerance phase (HBeAg positive, high viral load)
* co-infection with HIV, HCV
* malignant disease
* HCC or other liver tumor
18 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johann Wolfgang Goethe University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Georg Dultz
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Sarrazin, MD
Role: PRINCIPAL_INVESTIGATOR
Medizinische Klinik 1, Klinikum der J. W. Goethe-Universität Frankfurt am Main, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité Berlin-Campus Virchow-Klinikum
Berlin, , Germany
Klinikum der J. W. Goethe-Universität
Frankfurt, , Germany
Institut für Interdisziplinäre Medizin
Hamburg, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Gastroenterologische Gemeinschaftspraxis Herne
Herne, , Germany
Gastroenterologische Gemeinschaftspraxis Kiel
Kiel, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JWGUHMED1-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.